Cargando…
Pharmacogenomics of Hypertension Treatment
Hypertension is one of the strongest modifiable cardiovascular risk factors, affecting an increasing number of people worldwide. Apart from poor medication adherence, the low efficacy of some therapies could also be related to inter-individual genetic variability. Genetic studies of families reveale...
Autores principales: | Rysz, Jacek, Franczyk, Beata, Rysz-Górzyńska, Magdalena, Gluba-Brzózka, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369859/ https://www.ncbi.nlm.nih.gov/pubmed/32630286 http://dx.doi.org/10.3390/ijms21134709 |
Ejemplares similares
-
The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
por: Rysz, Jacek, et al.
Publicado: (2020) -
Ageing, Age-Related Cardiovascular Risk and the Beneficial Role of Natural Components Intake
por: Rysz, Jacek, et al.
Publicado: (2021) -
Are Alterations in DNA Methylation Related to CKD Development?
por: Rysz, Jacek, et al.
Publicado: (2022) -
The Role of Inflammation and Oxidative Stress in Rheumatic Heart Disease
por: Franczyk, Beata, et al.
Publicado: (2022) -
Is a High HDL-Cholesterol Level Always Beneficial?
por: Franczyk, Beata, et al.
Publicado: (2021)